Login to Your Account

Avanir Publishes Phase III Data For Neuropathic Pain Combo

By Catherine Shaffer
Staff Writer

Thursday, February 9, 2012
To create product candidate AVP-923, Avanir Pharmaceuticals Inc. bundled cough medicine dextromethorphan with antiarrhythmic agent quinidine. Now the duo of medicine cabinet staples has prevailed against an unrelated third indication: diabetic peripheral neuropathy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription